2018 Q1 Form 10-Q Financial Statement

#000114420418028602 Filed on May 15, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $1.149M $434.5K
YoY Change 164.52% 248.44%
Cost Of Revenue $587.5K $341.0K
YoY Change 72.26% 15.68%
Gross Profit $561.9K $93.47K
YoY Change 501.16% -154.95%
Gross Profit Margin 48.89% 21.51%
Selling, General & Admin $1.675M $1.017M
YoY Change 64.66% 71.17%
% of Gross Profit 298.16% 1088.54%
Research & Development $49.67K $44.70K
YoY Change 11.11% -47.79%
% of Gross Profit 8.84% 47.83%
Depreciation & Amortization $4.317K $447.00
YoY Change 865.77%
% of Gross Profit 0.77% 0.48%
Operating Expenses $1.725M $1.208M
YoY Change 42.84% 47.53%
Operating Profit -$1.163M -$1.114M
YoY Change 4.39% 12.69%
Interest Expense $237.00 $164.00
YoY Change 44.51% -100.15%
% of Operating Profit
Other Income/Expense, Net $465.00 $310.9K
YoY Change -99.85% -108.83%
Pretax Income -$1.160M -$800.0K
YoY Change 45.0% -82.26%
Income Tax
% Of Pretax Income
Net Earnings -$1.163M -$803.2K
YoY Change 44.75% -82.19%
Net Earnings / Revenue -101.15% -184.85%
Basic Earnings Per Share
Diluted Earnings Per Share -$179.3K -$178.6K
COMMON SHARES
Basic Shares Outstanding 112.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.280M $780.0K
YoY Change 64.1% -30.97%
Cash & Equivalents $1.277M $783.7K
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $90.00K $10.00K
YoY Change 800.0% -75.0%
Inventory
Prepaid Expenses
Receivables $137.3K $57.60K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.510M $860.0K
YoY Change 75.58% -27.73%
LONG-TERM ASSETS
Property, Plant & Equipment $41.57K $5.289K
YoY Change 685.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $60.00K
YoY Change
Total Long-Term Assets $2.910M $2.920M
YoY Change -0.34% -15.21%
TOTAL ASSETS
Total Short-Term Assets $1.510M $860.0K
Total Long-Term Assets $2.910M $2.920M
Total Assets $4.420M $3.780M
YoY Change 16.93% -18.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $60.00K $260.0K
YoY Change -76.92% -3.7%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $20.00K
YoY Change 0.0%
Total Short-Term Liabilities $1.449M $3.930M
YoY Change -63.14% -11.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $10.00K $10.00K
YoY Change 0.0%
Total Long-Term Liabilities $10.00K $10.00K
YoY Change 0.0% -99.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.449M $3.930M
Total Long-Term Liabilities $10.00K $10.00K
Total Liabilities $1.458M $3.950M
YoY Change -63.08% -38.25%
SHAREHOLDERS EQUITY
Retained Earnings -$38.29M -$34.62M
YoY Change 10.58% 20.42%
Common Stock $1.617K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.965M -$164.3K
YoY Change
Total Liabilities & Shareholders Equity $4.423M $3.781M
YoY Change 16.98% -18.4%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$1.163M -$803.2K
YoY Change 44.75% -82.19%
Depreciation, Depletion And Amortization $4.317K $447.00
YoY Change 865.77%
Cash From Operating Activities -$596.7K -$613.0K
YoY Change -2.66% 9.47%
INVESTING ACTIVITIES
Capital Expenditures $10.89K $5.736K
YoY Change 89.91%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$86.72K -$56.71K
YoY Change 52.93% 41.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $50.00K
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $44.00K
YoY Change -100.0% -540.0%
NET CHANGE
Cash From Operating Activities -596.7K -$613.0K
Cash From Investing Activities -86.72K -$56.71K
Cash From Financing Activities 0.000 $44.00K
Net Change In Cash -683.4K -$625.8K
YoY Change 9.22% 2.58%
FREE CASH FLOW
Cash From Operating Activities -$596.7K -$613.0K
Capital Expenditures $10.89K $5.736K
Free Cash Flow -$607.6K -$618.8K
YoY Change -1.81% 10.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
341042 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
93465 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4423331 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5034388 USD
CY2018Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
14467 USD
CY2017Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
23535 USD
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1448678 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4333329 USD
CY2018Q1 us-gaap Liabilities
Liabilities
1458465 USD
CY2017Q4 us-gaap Liabilities
Liabilities
4338377 USD
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
1 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
1617 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1617 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38285838 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39425900 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
2964866 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
696011 USD
CY2018Q1 us-gaap Cash
Cash
1276997 USD
CY2017Q4 us-gaap Cash
Cash
1960430 USD
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
137329 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105817 USD
CY2018Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
978 USD
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
1724954 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1114133 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1163076 USD
CY2017Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
164 USD
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
587464 USD
CY2018Q1 us-gaap Gross Profit
GrossProfit
561878 USD
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
279727 USD
CY2018Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
610662 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44702 USD
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49667 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
737681 USD
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
936960 USD
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
145488 USD
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
127665 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
1207598 USD
CY2018Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
237 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
310937 USD
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
465 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-803196 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-1162611 USD
CY2017Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
750 USD
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1233754 USD
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2984010 USD
CY2018Q1 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
3319 USD
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
9402 USD
CY2018Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
9787 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
783664 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1276997 USD
CY2018Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-18923 USD
CY2017Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-5871 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
69959 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
140464 USD
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
5048 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41570 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34994 USD
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41249086 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40120293 USD
CY2018Q1 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
13750 USD
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1176361 USD
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
434507 USD
CY2018Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1149342 USD
CY2018Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 USD
CY2017Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
310773 USD
CY2018Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
228 USD
CY2017Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
CY2018Q1 aeye Adjustments To Additional Paid In Capital Restricted Stock Units Warrant And Options Issued For Services
AdjustmentsToAdditionalPaidInCapitalRestrictedStockUnitsWarrantAndOptionsIssuedForServices
367303 USD
CY2017Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
145488 USD
CY2018Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
127665 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
211464 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
367303 USD
CY2017Q1 aeye Common Stock Issuance Costs
CommonStockIssuanceCosts
17875 USD
CY2018Q1 aeye Common Stock Issuance Costs
CommonStockIssuanceCosts
0 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12954 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31512 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11853 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-25954 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
51750 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-9068 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-613048 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-596715 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56706 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-86718 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
44000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-625754 USD
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-683433 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1409418 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1960430 USD
CY2017Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2018Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2018Q1 us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
1344 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
385 USD
CY2018Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 USD
CY2018Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2017Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2017Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
0 USD
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q1 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
0 USD
CY2017Q1 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
6062 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10893 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5736 USD
CY2017Q1 aeye Restricted Stock Units Issued In Payment Of Accrued Compensation
RestrictedStockUnitsIssuedInPaymentOfAccruedCompensation
58333 USD
CY2018Q1 aeye Restricted Stock Units Issued In Payment Of Accrued Compensation
RestrictedStockUnitsIssuedInPaymentOfAccruedCompensation
0 USD
CY2018Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
75825 USD
CY2017Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
50970 USD
CY2018Q1 aeye Working Capital Amount
WorkingCapitalAmount
59041 USD
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35968 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31651 USD
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
77538 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
66645 USD
CY2018Q1 us-gaap Depreciation
Depreciation
4317 USD
CY2017Q1 us-gaap Depreciation
Depreciation
447 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2661963 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2538615 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2164463 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2116940 USD
CY2017Q4 aeye Due To Related Party For Unreimbursed Travel Related Expenses
DueToRelatedPartyForUnreimbursedTravelRelatedExpenses
14000 USD
CY2018Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
10507 USD
CY2017Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1500 USD
CY2018Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
220864 USD
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
179563 USD
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
110000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
110000 shares
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
110000 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
110000 shares
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
161664077 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
161664077 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161664077 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161664077 shares
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
161664077 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
111884024 shares
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <font style="BACKGROUND-COLOR: transparent"><u>Use of Estimates</u></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company&#8217;s stock, stock-based compensation, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q1 aeye Due To Related Party For Unreimbursed Travel Related Expenses
DueToRelatedPartyForUnreimbursedTravelRelatedExpenses
8475 USD
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
81744441 shares
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
98181910 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1509436 shares
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.258
CY2018Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
43932 USD
CY2017Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
0 USD
CY2018Q1 us-gaap Deferred Costs
DeferredCosts
56574 USD
CY2017Q4 us-gaap Deferred Costs
DeferredCosts
0 USD
CY2018Q1 us-gaap Deferred Policy Acquisition Costs Text Block1
DeferredPolicyAcquisitionCostsTextBlock1
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>NOTE 5 &#151; DEFERRED COSTS</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Effective January 1, 2018, the Company capitalizes initial and renewal sales commission payments in the period a customer contract is obtained and payment is received; and is amortized consistent with the transfer of the goods or services to the customer over the expected period of benefit. The expected period of benefit is the contract term, except when the commission payment is expected to provide economic benefit to the Company for a period longer than the contract term, such as for new customer or incremental sales where renewals are expected and renewal commissions are not commensurate with initial commissions.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Such commissions are amortized over the greater of contract term or technological obsolescence period when the underlying contracted products are technology-based, such as for the SaaS-based platforms, or the expected customer relationship period when the underlying contracted products are not technology-based, such as for patient experience survey products.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">During the three months ended March 31, 2018, the Company deferred an aggregate $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30,327</font> commissions paid and reclassified from equity $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">80,153</font> previously paid and expensed commissions. Amortization of deferred costs for the three months ended March 31, 2018 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,974</font>.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
9974 USD
CY2017Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
0 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
30327 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 USD
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
The options are exercisable at $0.258 per share for five years with (i) 946,936 options vesting 50% at the first day of each month beginning January 1, 2018 through December 1, 2018, 25% vesting at the first day of each month from January 1, 2019 through December 1, 2019 and 25% vesting at the first day of each month beginning January 1, 2020 through December 1, 2020; (ii) 312,500 options vesting 50% on January 1, 2018, 50% vesting at each month beginning on January 1, 2019 for 24 months; and (iii) 250,000 options fully vesting on January 1, 2018. The exercise price was determined using the 10-day average closing price beginning with the closing price on January 9, 2018.
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
298914 shares
CY2018Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
857003 USD
CY2018Q1 aeye Deferred Revenue Payments
DeferredRevenuePayments
997467 USD

Files In Submission

Name View Source Status
0001144204-18-028602-index-headers.html Edgar Link pending
0001144204-18-028602-index.html Edgar Link pending
0001144204-18-028602.txt Edgar Link pending
0001144204-18-028602-xbrl.zip Edgar Link pending
aeye-20180331.xml Edgar Link completed
aeye-20180331.xsd Edgar Link pending
aeye-20180331_cal.xml Edgar Link unprocessable
aeye-20180331_def.xml Edgar Link unprocessable
aeye-20180331_lab.xml Edgar Link unprocessable
aeye-20180331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv493220_10q.htm Edgar Link pending
tv493220_ex31-1.htm Edgar Link pending
tv493220_ex32-1.htm Edgar Link pending
tv493220_img1.jpg Edgar Link pending